Home / Health / India's Cancer Fight: Screenings & Drug Duty Waivers Boost Hope
India's Cancer Fight: Screenings & Drug Duty Waivers Boost Hope
4 Feb
Summary
- Ayushman Arogya Mandirs are key in India's cancer detection efforts.
- India reported over 15.3 lakh new cancer cases and 8.7 lakh deaths in 2024.
- Customs duty on 17 cancer drugs has been waived to reduce treatment costs.
Ayushman Arogya Mandirs are significantly bolstering India's efforts in combating cancer, particularly through enhanced screening and early detection programs. Union Health Minister JP Nadda highlighted these initiatives on World Cancer Day, emphasizing the critical role of timely diagnosis and accessible treatment.
Recent data from the Indian Council of Medical Research (ICMR) indicates a substantial cancer burden, with over 15.3 lakh new cases and approximately 8.7 lakh deaths reported in India in 2024. Globally, the figures were even higher, with 20 million new cases and 9.7 million deaths in 2022.
In a move to improve affordability, the government has waived customs duty on 17 cancer drugs, a measure welcomed by health experts. This, alongside the establishment of cancer day care units in districts and new cancer institutes, aims to strengthen the healthcare system. The focus remains on early detection, prompt referral, and cost-effective treatment, with an eye towards public-private collaboration.
Looking ahead, advancements in technology, such as deep sequencing of DNA genes for personalized treatment and detecting tumors smaller than 5mm, are poised to revolutionize cancer care. The push towards adopting these advanced diagnostic tools is seen as the future of oncology.
